LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Enhancing the Peak Capacity of High Molecular Weight N-Glycan HILIC Separations with a Wide-Pore Amide Bonded Stationary Phase

Applications | 2015 | WatersInstrumentation
Consumables, HPLC, LC columns
Industries
Proteomics
Manufacturer
Waters

Summary

Significance of the Topic


Reliable analysis of N-linked glycans is fundamental to the development and quality control of biopharmaceuticals. Complex glycan structures, especially high molecular weight tri- and tetra-antennary species, influence efficacy, immunogenicity, and stability of glycoprotein therapeutics. Optimizing chromatographic resolution for these large glycans is therefore crucial for detailed profiling and regulatory compliance.

Study Objectives and Overview


This study evaluates the performance of a wide-pore amide bonded stationary phase (300 Å, 1.7 µm) compared to a conventional glycan column (130 Å, 1.7 µm) for UPLC-HILIC separations of RapiFluor-MS labeled N-glycans. Two sample types were examined: biantennary glycans from pooled human IgG and highly branched glycans from recombinant coagulation Factor IX.

Methodology and Instrumentation


Sample Preparation
  • Rapid deglycosylation and fluorescent/MS-active labeling using RapiFluor-MS reagent
  • μElution HILIC solid phase extraction following GlycoWorks kit protocol

Chromatographic Conditions
  • Separation by HILIC on ACQUITY UPLC columns (2.1×150 mm, 1.7 µm)
  • Comparative stationary phases: glycan BEH amide 130 Å vs glycoprotein BEH amide 300 Å
  • Mobile phase gradients and flow rates per GlycoWorks Care and Use Manual
  • Fluorescence detection of labeled glycans

Instrumentation Used


  • ACQUITY UPLC system
  • Glycan BEH amide column, 130 Å, 1.7 µm, 2.1×150 mm
  • Glycoprotein BEH amide column, 300 Å, 1.7 µm, 2.1×150 mm
  • RapiFluor-MS N-Glycan Kit
  • Fluorescence detector module

Results and Discussion


Chromatograms of IgG biantennary glycans showed similar peak capacities on both columns, indicating equivalent performance for smaller structures. In contrast, Factor IX tri- and tetra-antennary glycans exhibited a 17% increase in effective peak capacity on the 300 Å column (Pc 62 vs Pc 53). Peak widths at half height decreased from ~7.5 s to ~6.6 s, enhancing resolution of low-abundance species such as FA4G4 variants. Wide-pore pores allow large glycans unhindered access to the stationary phase network, reducing diffusional limitations and improving separation efficiency.

Benefits and Practical Applications


  • Enhanced resolving power for highly branched high molecular weight glycans
  • Improved detection of minor glycoforms critical for biosimilarity and lot release testing
  • Facilitated profiling of complex biotherapeutics including Factor IX erythropoietin and darbepoetin
  • Streamlined integration into existing UPLC-HILIC workflows

Future Trends and Applications


Further development may include coupling wide-pore HILIC separations with high-resolution mass spectrometry for intact glycoprotein analysis. Expansion of pore sizes and particle technologies could enhance performance for even larger biomolecules. Adoption in regulated labs will drive advances in automated glycan profiling and database matching.

Conclusion


The wide-pore (300 Å) BEH amide column offers a clear advantage for UPLC-HILIC separation of high molecular weight tri- and tetra-antennary N-glycans, delivering up to 17% greater peak capacity and improved resolution of low-abundance species. Conventional 130 Å columns remain suitable for smaller biantennary structures, while the 300 Å phase is recommended for detailed analysis of complex glycan profiles in biopharmaceutical development and quality control.

References


  1. Lauber MA Brousmiche DW Hua Z Koza SM Guthrie E Magnelli P Taron CH Fountain KJ Rapid preparation of released N-Glycans for HILIC analysis using a novel fluorescence and MS-active labeling reagent Waters Application Note 720005275EN 2015
  2. Ahn J Yu YQ Gilar M UPLC-FLR method development of 2-AB labeled glycan separation in hydrophilic interaction chromatography HILIC Waters Application Note 720003238EN 2010
  3. Gustavsson PE Larsson PO Support materials for affinity chromatography In Handbook of Affinity Chromatography Hage D Ed Taylor & Francis Boca Raton FL 2006 15–33
  4. Renkin EM Studies of diffusion through polymer membranes J Gen Physiol 1954 38 225
  5. Yu YQ Analysis of N-Linked Glycans from Coagulation Factor IX Recombinant and plasma derived using HILIC UPLC/FLR/QTof MS Waters Application Note 720004019EN 2011
  6. Waters GlycoWorks RapiFluor-MS N-Glycan Kit Care and Use Manual 715004793EN
  7. Campbell MP Royle L Radcliffe CM Dwek RA Rudd PM GlycoBase and autoGU tools for HPLC based glycan analysis Bioinformatics 2008 24 1214–1216
  8. Lauber MA Koza SM Developing high resolution HILIC separations of intact glycosylated proteins using a wide-pore amide bonded stationary phase Waters Application Note 720005380EN 2015

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Waters Application Notes - Glycans
Waters Application Notes Glycans There are a variety of complementary techniques practiced to get the complete story about a glycoprotein. Each technique varies in complexity and provides a different layer of information. Method complexity This application notebook highlights a body…
Key words
glycan, glycanrapifluor, rapifluorglycans, glycanshilic, hilicuplc, uplcacquity, acquityamide, amideglycoworks, glycoworksflr, flrreleased, releasedunifi, unifilabeled, labeledseparations, separationsglycosylation, glycosylationbeh
Mapping IgG Subunit Glycoforms Using HILIC and a Wide-Pore Amide Stationary Phase
Mapping IgG Subunit Glycoforms Using HILIC and a Wide-Pore Amide Stationary Phase Matthew A. Lauber and Stephan M. Koza Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I…
Key words
subunit, subunithilic, hilicamide, amideigg, iggglycoforms, glycoformsglycan, glycanseparations, separationsrapifluor, rapifluorpore, porecetuximab, cetuximabstationary, stationarymapping, mappingides, ideswide, wideglycoprotein
HILIC Glycopeptide Mapping with a Wide-Pore Amide Stationary Phase
HILIC Glycopeptide Mapping with a Wide-Pore Amide Stationary Phase Matthew A. Lauber and Stephan M. Koza Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I T S ■■…
Key words
hilic, hilicglycopeptide, glycopeptideamide, amidemapping, mappingglycoprotein, glycoproteinseparations, separationspore, porestationary, stationaryglycopeptides, glycopeptideslys, lysphase, phasecetuximab, cetuximabbeh, behwide, wideglycan
BIOSEPARATIONS - APPLICATIONS NOTEBOOK
MAIN MENU TABLE OF CONTENTS [ APPLICATIONS NOTEBOOK ] BIOSEPARATIONS Tools, Techniques, and Insights into Biopharmaceutical Analysis INT RODUCTION Biopharmaceuticals have emerged as a dominant class due to their specificity and efficacy. T he production of biopharmaceuticals, however, is distinctly…
Key words
menu, menuuplc, uplcglycan, glycanacquity, acquitymain, maincontents, contentsrapifluor, rapifluorglycans, glycanstable, tablehilic, hilicclass, classseparations, separationsbio, bioblend, blendglycoworks
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike